🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
January 2026
›
Biotechnology Industry
Insider Buy/Sell Details for the Biotechnology Industry — January 2026
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(95)
All (1179)
Buys (95)
Sells (1084)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
Surrozen, Inc./DE
(SRZN)
TCG Crossover GP II, LLC
— 10% Owner
Jan 30, 2026
Purchase
Shares
2,135
Price
$21.39
Total Value
$45.67K
Shares Held After
639,140
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Surrozen, Inc./DE
(SRZN)
TCG Crossover GP II, LLC
— 10% Owner
Jan 30, 2026
Purchase
Shares
2,136
Price
$21.39
Total Value
$45.69K
Shares Held After
639,141
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Aprea Therapeutics, Inc.
(APRE)
Hamill John P.
— SrVP/CFO/Prin Fin & Acct Ofcr
Jan 30, 2026
Purchase
Shares
5,700
Price
$0.89
Total Value
$5.07K
Shares Held After
33,433
% of Holdings
17.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Aprea Therapeutics, Inc.
(APRE)
Gilad Oren
— Director
Jan 30, 2026
Purchase
Shares
28,100
Price
$0.89
Total Value
$25.01K
Shares Held After
373,720
% of Holdings
7.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Anixa Biosciences, Inc.
(ANIX)
Baskies Arnold M
— Director
Jan 28, 2026
Purchase
Shares
10,000
Price
$3.04
Total Value
$30.40K
Shares Held After
135,000
% of Holdings
7.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sol-Gel Technologies Ltd.
(SLGL)
Opaleye Management Inc.
— 10% Owner
Jan 27, 2026
Purchase
Shares
100
Price
$57.05
Total Value
$5.71K
Shares Held After
449,944
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ZIVO Bioscience, Inc.
(ZIVO)
Cornell Alison A
— Director
Jan 26, 2026
Purchase
Shares
11,709
Price
$8.54
Total Value
$99.99K
Shares Held After
279,481
% of Holdings
4.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ZIVO Bioscience, Inc.
(ZIVO)
PAYNE JOHN BERNARD
— Director
Jan 26, 2026
Purchase
Shares
11,709
Price
$8.54
Total Value
$99.99K
Shares Held After
19,618
% of Holdings
59.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Mirum Pharmaceuticals, Inc.
(MIRM)
Heron Patrick J
— Director
Jan 23, 2026
Purchase
Shares
131,425
Price
$68.48
Total Value
$9.00M
Shares Held After
459,010
% of Holdings
28.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sol-Gel Technologies Ltd.
(SLGL)
Opaleye Management Inc.
— 10% Owner
Jan 23, 2026
Purchase
Shares
1,151
Price
$55.98
Total Value
$64.43K
Shares Held After
449,844
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CEL-SCI Corporation
(CVM)
KERSTEN GEERT R
— Director
Jan 22, 2026
Purchase
Shares
38,023
Price
$5.26
Total Value
$200.00K
Shares Held After
120,815
% of Holdings
31.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sol-Gel Technologies Ltd.
(SLGL)
Opaleye Management Inc.
— 10% Owner
Jan 22, 2026
Purchase
Shares
2,173
Price
$56.57
Total Value
$122.92K
Shares Held After
448,693
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
RenovoRx, Inc.
(RNXT)
Agah Ramtin
— Director
Jan 21, 2026
Purchase
Shares
10,000
Price
$1.00
Total Value
$9.97K
Shares Held After
798,460
% of Holdings
1.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Cabaletta Bio, Inc.
(CABA)
Chang David J.
— Chief Medical Officer
Jan 21, 2026
Purchase
Shares
8,800
Price
$2.26
Total Value
$19.89K
Shares Held After
8,800
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Cabaletta Bio, Inc.
(CABA)
Binder Gwendolyn
— President, Science & Tech.
Jan 21, 2026
Purchase
Shares
11,312
Price
$2.19
Total Value
$24.76K
Shares Held After
31,312
% of Holdings
36.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Cabaletta Bio, Inc.
(CABA)
Tomasello Shawn
— Director
Jan 21, 2026
Purchase
Shares
22,725
Price
$2.21
Total Value
$50.32K
Shares Held After
22,725
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Cabaletta Bio, Inc.
(CABA)
Gavel Steve
— Chief Commercial Officer
Jan 21, 2026
Purchase
Shares
22,170
Price
$2.27
Total Value
$50.22K
Shares Held After
22,170
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Cabaletta Bio, Inc.
(CABA)
Bollard Catherine
— Director
Jan 21, 2026
Purchase
Shares
4,405
Price
$2.27
Total Value
$9.98K
Shares Held After
5,405
% of Holdings
81.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Cabaletta Bio, Inc.
(CABA)
Nichtberger Steven
— Director
Jan 21, 2026
Purchase
Shares
45,000
Price
$2.24
Total Value
$100.78K
Shares Held After
1,031,483
% of Holdings
4.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Cabaletta Bio, Inc.
(CABA)
Simon Mark
— Director
Jan 21, 2026
Purchase
Shares
11,061
Price
$2.28
Total Value
$25.26K
Shares Held After
147,205
% of Holdings
7.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Cabaletta Bio, Inc.
(CABA)
Gerard Michael
— General Counsel
Jan 21, 2026
Purchase
Shares
6,600
Price
$2.27
Total Value
$14.98K
Shares Held After
6,600
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BioCardia, Inc.
(BCDA)
Altman Peter
— Director
Jan 21, 2026
Purchase
Shares
300
Price
$1.34
Total Value
$402.00
Shares Held After
268,866
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BioCardia, Inc.
(BCDA)
Altman Peter
— Director
Jan 20, 2026
Purchase
Shares
600
Price
$1.32
Total Value
$792.00
Shares Held After
268,566
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Surrozen, Inc./DE
(SRZN)
COLUMN GROUP III GP, LP
— 10% Owner
Jan 20, 2026
Purchase
Shares
9,568
Price
$19.60
Total Value
$187.53K
Shares Held After
1,016,658
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Surrozen, Inc./DE
(SRZN)
COLUMN GROUP III GP, LP
— 10% Owner
Jan 20, 2026
Purchase
Shares
8,484
Price
$19.60
Total Value
$166.29K
Shares Held After
900,292
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Surrozen, Inc./DE
(SRZN)
Kutzkey Tim
— Director
Jan 20, 2026
Purchase
Shares
9,568
Price
$19.60
Total Value
$187.53K
Shares Held After
1,016,658
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Surrozen, Inc./DE
(SRZN)
Kutzkey Tim
— Director
Jan 20, 2026
Purchase
Shares
8,484
Price
$19.60
Total Value
$166.29K
Shares Held After
900,292
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Palisade Bio, Inc.
(PALI)
Williams Donald Allen
— Director
Jan 16, 2026
Purchase
Shares
5,000
Price
$1.67
Total Value
$8.36K
Shares Held After
10,728
% of Holdings
46.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Immuneering Corp
(IMRX)
Brakewood Harold Eugene
— Chief Business Officer
Jan 16, 2026
Purchase
Shares
5,250
Price
$4.76
Total Value
$24.99K
Shares Held After
11,050
% of Holdings
47.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Surrozen, Inc./DE
(SRZN)
COLUMN GROUP III GP, LP
— 10% Owner
Jan 16, 2026
Purchase
Shares
1,358
Price
$20.00
Total Value
$27.16K
Shares Held After
1,007,090
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Surrozen, Inc./DE
(SRZN)
COLUMN GROUP III GP, LP
— 10% Owner
Jan 16, 2026
Purchase
Shares
1,204
Price
$20.00
Total Value
$24.08K
Shares Held After
891,808
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Surrozen, Inc./DE
(SRZN)
Kutzkey Tim
— Director
Jan 16, 2026
Purchase
Shares
1,358
Price
$20.00
Total Value
$27.16K
Shares Held After
1,007,090
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Surrozen, Inc./DE
(SRZN)
Kutzkey Tim
— Director
Jan 16, 2026
Purchase
Shares
1,204
Price
$20.00
Total Value
$24.08K
Shares Held After
891,808
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ONCOLYTICS BIOTECH INC
(ONCY)
Seizinger Bernd R.
— Director
Jan 16, 2026
Purchase
Shares
100,000
Price
$1.04
Total Value
$103.77K
Shares Held After
466,991
% of Holdings
21.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Immuneering Corp
(IMRX)
Hall Brett Matthew
— CHIEF SCIENTIFIC OFFICER
Jan 15, 2026
Purchase
Shares
2,298
Price
$4.57
Total Value
$10.50K
Shares Held After
376,496
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Surrozen, Inc./DE
(SRZN)
COLUMN GROUP III GP, LP
— 10% Owner
Jan 15, 2026
Purchase
Shares
6,303
Price
$19.89
Total Value
$125.36K
Shares Held After
1,005,732
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Surrozen, Inc./DE
(SRZN)
COLUMN GROUP III GP, LP
— 10% Owner
Jan 15, 2026
Purchase
Shares
5,590
Price
$19.89
Total Value
$111.18K
Shares Held After
890,604
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Surrozen, Inc./DE
(SRZN)
Kutzkey Tim
— Director
Jan 15, 2026
Purchase
Shares
6,303
Price
$19.89
Total Value
$125.36K
Shares Held After
1,005,732
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Surrozen, Inc./DE
(SRZN)
Kutzkey Tim
— Director
Jan 15, 2026
Purchase
Shares
5,590
Price
$19.89
Total Value
$111.18K
Shares Held After
890,604
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Immuneering Corp
(IMRX)
Schall Thomas J.
— Director
Jan 15, 2026
Purchase
Shares
21,645
Price
$4.67
Total Value
$101.04K
Shares Held After
74,530
% of Holdings
29.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Acrivon Therapeutics, Inc.
(ACRV)
Blume-Jensen Peter
— Director
Jan 14, 2026
Purchase
Shares
49,000
Price
$1.68
Total Value
$82.12K
Shares Held After
2,095,771
% of Holdings
2.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Acrivon Therapeutics, Inc.
(ACRV)
Levy Adam D.
— Chief Financial Officer
Jan 14, 2026
Purchase
Shares
8,832
Price
$1.70
Total Value
$15.00K
Shares Held After
20,983
% of Holdings
42.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ZIVO Bioscience, Inc.
(ZIVO)
Maggiore Christopher D.
— Director
Jan 14, 2026
Purchase
Shares
1,766
Price
$8.49
Total Value
$14.99K
Shares Held After
519,292
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ZIVO Bioscience, Inc.
(ZIVO)
YALDOO LAITH L
— Director
Jan 14, 2026
Purchase
Shares
1,766
Price
$8.49
Total Value
$14.99K
Shares Held After
579,638
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Surrozen, Inc./DE
(SRZN)
Kutzkey Tim
— Director
Jan 14, 2026
Purchase
Shares
2,927
Price
$19.99
Total Value
$58.51K
Shares Held After
999,429
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Surrozen, Inc./DE
(SRZN)
Kutzkey Tim
— Director
Jan 14, 2026
Purchase
Shares
2,596
Price
$19.99
Total Value
$51.89K
Shares Held After
885,014
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Surrozen, Inc./DE
(SRZN)
COLUMN GROUP III GP, LP
— 10% Owner
Jan 14, 2026
Purchase
Shares
2,927
Price
$19.99
Total Value
$58.51K
Shares Held After
999,429
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Surrozen, Inc./DE
(SRZN)
COLUMN GROUP III GP, LP
— 10% Owner
Jan 14, 2026
Purchase
Shares
2,596
Price
$19.99
Total Value
$51.89K
Shares Held After
885,014
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Acrivon Therapeutics, Inc.
(ACRV)
Devroe Eric
— Chief Operating Officer
Jan 13, 2026
Purchase
Shares
10,000
Price
$1.72
Total Value
$17.22K
Shares Held After
75,308
% of Holdings
13.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Surrozen, Inc./DE
(SRZN)
Kutzkey Tim
— Director
Jan 13, 2026
Purchase
Shares
6,609
Price
$19.80
Total Value
$130.89K
Shares Held After
996,502
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Next →
Showing 1–50 of 95 transactions (page 1 of 2)
Version: v26.3.23